Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P030036/S157

SelectSecure Lead

Medtronic Cardiac Rhythm Disease Management · Decision date Mar 6, 2026

FDA DECISIONP030036/S157

What did the FDA decide?

FDA records P030036/S157 as a supplement to PMA P030036, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Mar 6, 2026.

FDA approval order statement

expanding the existing lead repackaging process to include additional trigger defects
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Mar 6, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P030036/S157
Regulatory pathway
PMA supplement
Product code
NVN
Decision code
OK30
Decision date
Mar 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.

Product code
NVN
FDA device class
3

For the original device and its historical approval scope, see PMA P030036. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P030036 · Original PMA

    MEDTRONIC SELECTSECURE LEAD MODEL 3830

  2. P030036/S154 · Related supplement

    MEDTRONIC SELECTSECURE LEAD MODEL 3830

  3. P030036/S157 received

    Application receipt date recorded by FDA.

  4. P030036/S157 · FDA decision

    30-Day Notice

  5. P030036/S159 · Related supplement

    Anchoring Sleeve Kit; SelectSecure Lead

  6. P030036/S158 · Related supplement

    SelectSecure Lead Model 3830

  7. P030036/S160 · Related supplement

    SelectSecure Lead (3830)

  8. P030036/S162 · Related supplement

    MEDTRONIC SELECTSECURE LEAD MODEL 3830

Timeline entries are records held by MedtechLedger for P030036. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030036

Explore the linked device profile

Other records with product code NVN

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records